CASI PHARMACEUTICALS, INC. Payments to Acquire in Process Research and Development
CASI PHARMACEUTICALS, INC. (CASIF) reported Payments to Acquire in Process Research and Development of $6.55 million for the 12-month period ending 2021-12-31, per its 20-F filed 2024-03-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment · last filed 2024-03-28
| Period end | Payments to Acquire in Process Research and Development 12 month |
|---|---|
| 2021-12-31 | $6.55M 20-F · filed 2024-03-28 |
| 2020-12-31 | $17.83M 20-F · filed 2023-04-26 |